期刊文献+

Small-for-size syndrome in liver transplantation:Definition,pathophysiology and management 被引量:16

下载PDF
导出
摘要 Background:Since the first success in an adult patient,living donor liver transplantation(LDLT)has become an universally used procedure.Small-for-size syndrome(SFSS)is a well-known complication after partial LT,especially in cases of adult-to-adult LDLT.The definition of SFSS slightly varies among transplant physicians.The use of a partial liver graft has risks of SFSS development.Persistent portal vein(PV)hypertension and PV hyper-perfusion after LT were identified as the main factors.Hence,various approaches were explored to modulate PV flow and decrease PV pressure in order to alleviate this syndrome.Herein,the definition,clinical symptoms,pathophysiology,basic research,as well as preventive and treatment strategies for SFSS are reviewed based on an extensive review of the literature and on our own experiences.Data sources:The articles were collected through PubMed using search terms“liver transplantation”,“living donor liver transplantation”,“living liver donation”,“partial graft”,“small-for-size graft”,“small-forsize syndrome”,“graft volume”,“remnant liver”,“standard liver volume”,“graft to recipient body weight ratio”,“sarcopenia”,“porcine”,“swine”,and“rat”.English publications published before March 31,2020 were included in this review.Results:Many transplant surgeons performed PV flow modulation,including portocaval shunt,splenic artery ligation and splenectomy.With these techniques,patient outcome has been improved even when using a"small"graft.Other factors,such as preoperative recipients’nutritional and skeletal muscle status,graft congestion,and donor factors,were also identified as risk factors which all have been addressed using various strategies.Conclusions:The surgical approach controlling PV flow and pressure could help to prevent SFSS especially in severely ill recipients.In the absence of efficacious medications to resolve SFSS,conservative treatments,including aggressive fluid balance correction for massive ascites,anti-microbiological therapy to prevent or control sepsis and intensive nutritional therapy,are all required if SFSS could not be prevented.
出处 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2020年第4期334-341,共8页 国际肝胆胰疾病杂志(英文版)
  • 相关文献

参考文献5

二级参考文献39

  • 1Seung Duk Lee,Seong Hoon Kim,Young-Kyu Kim,Soon-Ae Lee,Sang-Jae Park.Graft-to-recipient weight ratio lower to 0.7% is safe without portal pressure modulation in right-lobe living donor liver transplantation with favorable conditions[J].Hepatobiliary & Pancreatic Diseases International,2014,13(1):18-24. 被引量:8
  • 2WANG Xue-hao,YAN Lü-nan,ZHANG Feng,LI Xiang-cheng,ZHU Ji-ye,PENG Zhi-hai,LIU Jin-hui,LI Guo-qiang,CHENG Feng,SUN Bei-cheng,GE Wen-gang.Early experiences on living donor liver transplantation in China: multicenter report[J].Chinese Medical Journal,2006(12):1003-1009. 被引量:7
  • 3Seong Hoon Kim,Young Kyu Kim.Living Donor Right Hepatectomy Using the Hanging Maneuver by Glisson’s Approach Under the Upper Midline Incision[J]. World Journal of Surgery . 2012 (2)
  • 4T. Kaido,A. Mori,Y. Ogura,K. Hata,A. Yoshizawa,T. Iida,S. Yagi,S. Uemoto.Lower Limit of the Graft-to-Recipient Weight Ratio Can Be Safely Reduced to 0.6% in Adult-to-Adult Living Donor Liver Transplantation in Combination with Portal Pressure Control[J]. Transplantation Proceedings . 2011 (6)
  • 5T.Yamada,K.Tanaka,K.Uryuhara,K.Ito,Y.Takada,S.Uemoto.Selective Hemi‐Portocaval Shunt Based on Portal Vein Pressure for Small‐for‐Size Graft in Adult Living Donor Liver Transplantation[J]. American Journal of Transplantation . 2008 (4)
  • 6Anthony J. Demetris,Dympna M. Kelly,Bijan Eghtesad,Paulo Fontes,J. Wallis Marsh,Kusum Tom,Heinke P. Tan,Thomas Shaw-Stiffel,Linda Boig,Paula Novelli,Raymond Planinsic,John J. Fung,Amadeo Marcos.Pathophysiologic Observations and Histopathologic Recognition of the Portal Hyperperfusion or Small-for-Size Syndrome[J]. The American Journal of Surgical Pathology . 2006 (8)
  • 7Chung-Mau Lo,Chi-Leung Liu,Sheung-Tat Fan.Portal hyperperfusion injury as the cause of primary nonfunction in a small-for-size liver graft-successful treatment with splenic artery ligation[J]. Liver Transplantation . 2003 (6)
  • 8Tetsuya Kiuchi,Koichi Tanaka,Takashi Ito,Fumitaka Oike,Yasuhiro Ogura,Yasuhiro Fujimoto,Kohei Ogawa.Small-for-size graft in living donor liver transplantation: How far should we go?[J]. Liver Transplantation . 2003 (9)
  • 9Chao-Long Chen,Sheung-Tat Fan,Sung-Gyu Lee,Masatoshi Makuuchi,Koichi Tanaka.Living-donor liver transplantation: 12 years of experience in Asia[J]. Transplantation . 2003 (3 Suppl)
  • 10Takashi Ito,Tetsuya Kiuchi,Hidekazu Yamamoto,Fumitaka Oike,Yasuhiro Ogura,Yasuhiro Fujimoto,Kazuhiro Hirohashi,and Koichi Tanaka.Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications1,2[J]. Transplantation . 2003 (8)

共引文献44

同被引文献111

引证文献16

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部